Literature DB >> 35723116

Infections and Changes in Commensal Bacteria and the Pathogenesis of Parkinson's Disease.

Kathleen M Shannon1.   

Abstract

The cause of Parkinson's disease (PD) is unknown, but environmental factors are purported to influence risk. Interest in PD as a sequel of infection dates back to reports of parkinsonism arising from encephalitis lethargica. The objective of this paper is to review the literature as it relates to infections and changes in microbiome and the genesis of PD. There is evidence to support prior infection with Helicobacter pylori, hepatitis C virus, Malassezia, and Strep pneumonia in association with PD. A large number of studies support an association between changes in commensal bacteria, especially gut bacteria, and PD. Extant literature supports a role for some infections and changes in commensal bacteria in the genesis of PD. Studies support an inflammatory mechanism for this association, but additional research is required for translation of these findings to therapeutic options.

Entities:  

Keywords:  Parkinson’s disease; infections; microbiota; neuroinflammation; review

Mesh:

Year:  2022        PMID: 35723116      PMCID: PMC9535579          DOI: 10.3233/JPD-223271

Source DB:  PubMed          Journal:  J Parkinsons Dis        ISSN: 1877-7171            Impact factor:   5.520


  45 in total

Review 1.  Chronic stress-induced gut dysfunction exacerbates Parkinson's disease phenotype and pathology in a rotenone-induced mouse model of Parkinson's disease.

Authors:  Hemraj B Dodiya; Christopher B Forsyth; Robin M Voigt; Phillip A Engen; Jinal Patel; Maliha Shaikh; Stefan J Green; Ankur Naqib; Avik Roy; Jeffrey H Kordower; Kalipada Pahan; Kathleen M Shannon; Ali Keshavarzian
Journal:  Neurobiol Dis       Date:  2018-12-21       Impact factor: 5.996

Review 2.  Microbiome 101: Studying, Analyzing, and Interpreting Gut Microbiome Data for Clinicians.

Authors:  Celeste Allaband; Daniel McDonald; Yoshiki Vázquez-Baeza; Jeremiah J Minich; Anupriya Tripathi; David A Brenner; Rohit Loomba; Larry Smarr; William J Sandborn; Bernd Schnabl; Pieter Dorrestein; Amir Zarrinpar; Rob Knight
Journal:  Clin Gastroenterol Hepatol       Date:  2018-09-18       Impact factor: 11.382

Review 3.  H. pylori and Parkinson's disease: Meta-analyses including clinical severity.

Authors:  Efthimios Dardiotis; Zisis Tsouris; Alexios-Fotios A Mentis; Vasileios Siokas; Amalia Michalopoulou; Maria Sokratous; Metaxia Dastamani; Dimitrios P Bogdanos; Georgia Deretzi; Jannis Kountouras
Journal:  Clin Neurol Neurosurg       Date:  2018-10-01       Impact factor: 1.876

4.  Neuroprotective effects of fecal microbiota transplantation on MPTP-induced Parkinson's disease mice: Gut microbiota, glial reaction and TLR4/TNF-α signaling pathway.

Authors:  Meng-Fei Sun; Ying-Li Zhu; Zhi-Lan Zhou; Xue-Bing Jia; Yi-Da Xu; Qin Yang; Chun Cui; Yan-Qin Shen
Journal:  Brain Behav Immun       Date:  2018-02-20       Impact factor: 7.217

5.  Spread of aggregates after olfactory bulb injection of α-synuclein fibrils is associated with early neuronal loss and is reduced long term.

Authors:  Nolwen L Rey; Sonia George; Jennifer A Steiner; Zachary Madaj; Kelvin C Luk; John Q Trojanowski; Virginia M-Y Lee; Patrik Brundin
Journal:  Acta Neuropathol       Date:  2017-12-05       Impact factor: 17.088

6.  Toxoplasma gondii exposure and Parkinson's disease: a case-control study.

Authors:  Cosme Alvarado-Esquivel; Edna Madai Méndez-Hernández; José Manuel Salas-Pacheco; Luis Ángel Ruano-Calderón; Jesús Hernández-Tinoco; Oscar Arias-Carrión; Luis Francisco Sánchez-Anguiano; Francisco Xavier Castellanos-Juárez; Ada Agustina Sandoval-Carrillo; Oliver Liesenfeld; Agar Ramos-Nevárez
Journal:  BMJ Open       Date:  2017-02-13       Impact factor: 2.692

7.  The nasal and gut microbiome in Parkinson's disease and idiopathic rapid eye movement sleep behavior disorder.

Authors:  Anna Heintz-Buschart; Urvashi Pandey; Tamara Wicke; Friederike Sixel-Döring; Annette Janzen; Elisabeth Sittig-Wiegand; Claudia Trenkwalder; Wolfgang H Oertel; Brit Mollenhauer; Paul Wilmes
Journal:  Mov Disord       Date:  2017-08-26       Impact factor: 10.338

8.  Malassezia and Parkinson's Disease.

Authors:  Martin Laurence; Julián Benito-León; Frédéric Calon
Journal:  Front Neurol       Date:  2019-07-24       Impact factor: 4.003

9.  Deep nasal sinus cavity microbiota dysbiosis in Parkinson's disease.

Authors:  Gian Pal; Vivian Ramirez; Phillip A Engen; Ankur Naqib; Christopher B Forsyth; Stefan J Green; Mahboobeh Mahdavinia; Pete S Batra; Bobby A Tajudeen; Ali Keshavarzian
Journal:  NPJ Parkinsons Dis       Date:  2021-12-08

Review 10.  Brain-First versus Gut-First Parkinson's Disease: A Hypothesis.

Authors:  Per Borghammer; Nathalie Van Den Berge
Journal:  J Parkinsons Dis       Date:  2019       Impact factor: 5.568

View more
  1 in total

Review 1.  The Antimicrobial Properties of Cannabis and Cannabis-Derived Compounds and Relevance to CB2-Targeted Neurodegenerative Therapeutics.

Authors:  HeeJue Hong; Lucy Sloan; Deepak Saxena; David A Scott
Journal:  Biomedicines       Date:  2022-08-12
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.